Parameter
| Biomarker | NUP160-SLC43A3 fusion gene | Full name | Nucleoporin 160 kDa::Solute carrier family 43 member 3 gene fusion | Molecular Type | Nucleic acid (RNA/DNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | 200-250 kDa | Core Functional Dimensions | Diagnostic and therapeutic targets | |
| Disease | Angiosarcoma | Disease Subtypes | / | ||
| Organ | Vascular endothelial cells, tumor cells | Test Sample / Technology Platform | Tissue (NGS, RNA sequencing) | ||
| Pathobiological Mechanisms | Fusion gene drive endothelial cell malignant transformation | ||||
| Clinical Availability Status | Validation: primary scalp AS in common | ||||
| Notes and Dynamics | About 36% of primary scalp AS the fusion, has the subtype specificity | ||||